Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative
the RECOVER Consortium
Division of Infectious Diseases
Research output
:
Contribution to journal
›
Review article
›
peer-review
44
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Postcovid Syndrome
83%
Combination Therapy
66%
COVID-19
50%
Severe Acute Respiratory Syndrome Coronavirus 2
50%
Symptom
33%
Comprehension
33%
Diseases
16%
Biological Product
16%
Antigen
16%
Sequela
16%
Virus Infection
16%
Infection
16%
Immune Dysregulation
16%
Dysbiosis
16%
Motivation
16%
Health
16%
Gut
16%
Adoption
16%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
SARS Coronavirus
50%
Electric Potential
33%
Comprehension
33%
Experimentation
16%
Motivation
16%
Health
16%
Genetics
16%
Pharmacology, Toxicology and Pharmaceutical Science
Symptom
33%
Diseases
16%
Biological Product
16%
Antigen
16%
Infection
16%
Virus Infection
16%
Dysbiosis
16%
Immune Dysregulation
16%
Neuroscience
Antigen
16%